Business Wire

Cargill Puts Bold Innovation at Center of Effort to Decarbonize Shipping

15.1.2025 08:00:00 CET | Business Wire | Press release

Share

Continued investment in wind assisted propulsion, next-generation fuels and digital solutions key to moving the world’s goods more sustainably

Cargill is advancing a new era in sustainable shipping, putting innovation and collaboration at the core of its mission to move goods responsibly across the globe. Through wind-assisted propulsion technologies, dual-fuel methanol-powered vessels, and digital solutions, Cargill is setting the standard for helping the industry advance progress toward the International Maritime Organization’s (IMO) 2050 net-zero target. Combining technical expertise with a commitment to industry-wide partnerships, Cargill is helping to future-proof the maritime sector while enabling customers to meet their sustainability goals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114753261/en/

“Decarbonizing shipping is a monumental task that requires courage, innovation, and collaboration,” said Jan Dieleman, president of Cargill’s Ocean Transportation business. “Our role extends beyond freight-shipping services; we aim to catalyze a shift across the industry toward sustainable practices. Through strategic investments in cutting-edge technology and robust partnerships, we are accelerating the journey to net-zero emissions in shipping.”

Innovating with Wind-Assisted Propulsion: The Pyxis Ocean and Beyond

Leading the charge in wind-assisted propulsion, the Pyxis Ocean—the first dry bulk vessel equipped with BAR Technologies’ WindWings®—completed its maiden voyage in 2023. WindWings are large, rigid sails that harness wind power to reduce fuel use and emissions.

In addition to WindWings, Cargill has expanded its wind-assisted technology program to include VentoFoil vertical suction sails on the NBA Magritte and rotor sails on the TR Lady. With these three vessels the company is experimenting and learning before scaling up technical, operational and commercial aspects. These technologies further utilize wind power to decrease fuel dependency and emissions, aligning with the IMO's target to have 5-10% of maritime energy from renewable sources by 2030.

Cargill believes that wind could make an important contribution to achieving decarbonization goals in the short, medium, and long term. Dieleman says that while the cost of fuels that could contribute to a zero-carbon future may remain high, developing, testing, and improving wind assisted propulsion technologies before these fuels are available could reduce reliance on them.

Transforming Fuels: Biofuels and Methanol-Powered Vessels

Alongside wind propulsion, Cargill is transforming fuel usage across its fleet. The company is pioneering biofuels made from renewable sources, such as fatty acid methyl esters (FAME), providing a drop-in fuel option to lower emissions without extensive engine modifications. In 2023, the company moved from trialing these fuels to frequent execution as it prepares to scale up. Nearly 172,000 metric tons of biofuel blends containing 63,000 metric tons of FAME was lifted in 2023. Cargill is also the first dry-bulk charterer to sign commercial agreements for dual-fuel methanol-powered ships, which are expected to be operational within the next two years. Methanol, a low-carbon alternative fuel, offers a scalable pathway to zero emissions. These methanol-powered vessels—the first of their kind in commercial service—highlight Cargill’s proactive approach in adopting sustainable fuel solutions to support both its own and its customers’ ambitious Scope 3 emissions reduction goals.

Harnessing Digital Solutions for Efficiency and Sustainability

Digital innovation is also central to Cargill ’s decarbonization efforts. Cargill is using advanced digital tools, including voyage optimization technologies, to create digital twins of its vessels. This enables optimal speed and route planning to reduce fuel consumption and emissions. Partnering with ZeroNorth, Cargill leverages these digital solutions to enhance operational efficiency and sustainability, reinforcing its commitment to data-driven progress toward net-zero.

Building a Sustainable Future Through Collaboration

Recognizing that decarbonizing the maritime industry requires a collaborative approach, Cargill partners across the sector to drive meaningful progress. As a founding member of the Maersk Mc-Kinney Moller Center for Zero Carbon Shipping, Cargill works with industry leaders to test and promote alternative fuels, including ammonia and methanol. Cargill is also a key player in the Sea Cargo Charter, a coalition dedicated to reducing shipping’s climate impact through transparency and shared decarbonization frameworks.

“As we continue this journey, we’re focused on solutions that don’t just improve our own operations but drive change across the industry,” added Dieleman. “Our vision is a shipping sector that delivers the goods the world needs while protecting our planet’s future. We’re proud to be part of this transformation and are committed to building a more sustainable future for global shipping.”

For additional information about Cargill’s efforts to decarbonize shipping, visit https://www.cargill.com/transportation/ocean-transportation-sustainability.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our 160,000 team members innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 159 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114753261/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye